Thomas Tu - 27 Oct 2021 Form 4 Insider Report for Inari Medical, Inc.

Role
Chief Medical Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Issuer symbol
N/A
Transactions as of
27 Oct 2021
Net transactions value
-$436,091
Form type
4
Filing time
28 Oct 2021, 21:43:04 UTC
Previous filing
04 Oct 2021
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $2,285 +5,000 +10% $0.4570* 53,612 27 Oct 2021 Direct
transaction NARI Common Stock Sale $378,235 -4,320 -8.1% $87.55 49,292 27 Oct 2021 Direct F1, F2
transaction NARI Common Stock Sale $60,141 -680 -1.4% $88.44 48,612 27 Oct 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Option Options Exercise $0 -5,000 -2.3% $0.000000 215,584 27 Oct 2021 Common Stock 5,000 $0.4570 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $87.12 to $88.03 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $88.20 to $88.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Option vested with respected with 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.